1.Phamacologic Treatment for Peripheral Arterial Disease: Antithrombotic Drugs.
Journal of the Korean Society for Vascular Surgery 2003;19(2):227-229
No abstract available.
Peripheral Arterial Disease*
2.Pharmacologic Treatment for Peripheral Arterial Disease Patient: General Introduction.
Journal of the Korean Society for Vascular Surgery 2003;19(2):225-226
No abstract available.
Humans
;
Peripheral Arterial Disease*
3.Peripheral arterial disease.
Korean Journal of Medicine 2004;67(4):430-434
No abstract available.
Peripheral Arterial Disease*
4.Diagnosis and Treatment of Peripheral Arterial Disease.
Journal of the Korean Academy of Family Medicine 2008;29(6):387-394
No abstract available.
Peripheral Arterial Disease
5.Thallium-201 perfusion scan in peripheral arterial disease.
Jung Il NAH ; In Sook WOO ; Deog Yoon KIM ; Eun Mi KOH ; Jin Woo KIM ; Young Seol KIM ; Kwang Woo KIM ; Young Kil CHOI
Korean Journal of Nuclear Medicine 1991;25(2):192-199
No abstract available.
Perfusion*
;
Peripheral Arterial Disease*
6.Elucidation of the Diagnosis and Treatment of Peripheral Arterial Disease
Korean Circulation Journal 2018;48(9):826-827
No abstract available.
Diagnosis
;
Peripheral Arterial Disease
7.A clinical study of peripheral arterial disease.
Soo Bong HAHN ; Nam Hyun KIM ; Byeong Mun PARK ; Hak Sun KIM
The Journal of the Korean Orthopaedic Association 1991;26(2):461-468
No abstract available.
Peripheral Arterial Disease*
9.Ankle-brachial index as a predictor of one-year prognosis in ischemic stroke patients
Hyun Goo Kang ; In Sung Choo ; Bum Joon Kim ; Seong Hwan Ahn
Neurology Asia 2016;21(3):217-224
Objective: Peripheral arterial disease (PAD) reduces functional activity and increases the rate of
cardiovascular death in the elderly. Our study aimed to determine whether the presence of PAD in
stroke patients affected the progression of disability or death one year after discharge. Methods: From
April 2012 to March 2013, consecutive first stroke patients above 50 years of age without known PAD
were enrolled. PAD was defined as a low ankle-brachial index (less than 0.9) measured by an automatic
device. Clinical data associated with the stroke were collected from medical records. Disability in stroke
patients was evaluated with the modified Rankin scale (mRS) on discharge day and one year after the
index stroke. Progression of disability was defined as an increase in mRS more than one level at one
year. Results: Among the 526 patients, 238 had ischemic strokes and underwent ankle-brachial index
(ABI) measurement. Of them, 192 patients were included. In univariate analysis, age, dyslipidemia,
discharge mRS, low-density lipoprotein cholesterol, D-dimer, homocysteine, internal carotid artery
stenosis, posterior cerebral artery stenosis, and PAD were factors associated with worsening mRS.
After adjustment for these factors in the logistic regression analysis, PAD was an independent factor
associated with worsening mRS. In the analysis of one-year mortality, patients with PAD had a higher
death rate, but PAD was not an independent factor after adjusting for other variables.
Conclusions: The presence of PAD in stroke patients suggests a chance of disability progression, but
may not be a predictor of death after one year.
Atherosclerosis
;
Peripheral arterial disease
;
Stroke
10.Anesthetic complications due to extremely low ankle blood pressure caused by peripheral arterial disease.
Jae Chan CHOI ; Sang Hun LEE ; Soon Yul KIM ; Jong Hyuk LEE ; Kyu Yong JANG
Korean Journal of Anesthesiology 2013;64(2):191-193
No abstract available.
Animals
;
Ankle
;
Blood Pressure
;
Peripheral Arterial Disease
Result Analysis
Print
Save
E-mail